Ambrisentan therapy for pulmonary arterial hypertension.

Galié N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, Frost AE, Zwicke D, Naeije R, Shapiro S, Olschewski H, Rubin LJ. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2005 Aug 02; 46(3):529-35.

View in: PubMed

subject areas

Adult
Aged
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Exercise Tolerance
Female
Follow-Up Studies
Hemodynamics
Humans
Hypertension, Pulmonary
Male
Maximum Tolerated Dose
Middle Aged
Phenylpropionates
Probability
Pyridazines
Reference Values
Risk Assessment
Severity of Illness Index
Treatment Outcome
Vascular Resistance

authors with profiles

David B Badesch